Distinguished in Asthma in Children

Dr. John A. Belperio

Pulmonary Medicine
The Regents Of The University Of California
200 Medical Plaza, 
Los Angeles, CA 
Offers Telehealth
Distinguished in Asthma in Children
The Regents Of The University Of California
200 Medical Plaza, 
Los Angeles, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

John Belperio is a Pulmonary Medicine provider in Los Angeles, California. Dr. Belperio is rated as a Distinguished provider by MediFind in the treatment of Asthma in Children. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Bronchiolitis Obliterans, Lung Transplant, and Endoscopy.

His clinical research consists of co-authoring 145 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Licenses
Internal Medicine in CA
Hospital Affiliations
Ronald Reagan UCLA Medical Center
UCLA West Valley Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
200 Medical Plaza, Los Angeles, CA 90095
Other Locations
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
900 Weyburn Place, Suite 14 171, Los Angeles, CA 90095
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2020 Santa Monica Blvd, Suite 210, Santa Monica, CA 90404

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Clinical Trials in Organ Transplantation Extension Study (CTOT-ES)
Clinical Trials in Organ Transplantation Extension Study (CTOT-ES)
Enrollment Status: Completed
Publish Date: March 21, 2025
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug, Other
Study Drug: ND-L02-s0201
Study Phase: Phase 2
Potential Therapy With MACITENTAN in the Treatment of Chronic Lung Allograft Dysfunction (CLAD) After Lung Transplantation
Potential Therapy With MACITENTAN in the Treatment of Chronic Lung Allograft Dysfunction (CLAD) After Lung Transplantation
Enrollment Status: Withdrawn
Publish Date: December 11, 2020
Intervention Type: Drug
Study Phase: Phase 4
A Prospective Single Center Randomized Trial of Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation.
A Prospective Single Center Randomized Trial of Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation.
Enrollment Status: Withdrawn
Publish Date: September 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Prospective Multicenter Observational Cohort Study to Define the Risks Factors, Mechanisms, and Manifestations of Chronic Lung Allograft Dysfunction (CLAD) Phenotypes (CTOT-20)
A Prospective Multicenter Observational Cohort Study to Define the Risks Factors, Mechanisms, and Manifestations of Chronic Lung Allograft Dysfunction (CLAD) Phenotypes (CTOT-20)
Enrollment Status: Completed
Publish Date: December 17, 2019
Intervention Type: Procedure
Treatment of Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Hypertension With Bosentan: A Single Center Pilot Study
Treatment of Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Hypertension With Bosentan: A Single Center Pilot Study
Enrollment Status: Withdrawn
Publish Date: March 06, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 6 Less Clinical Trials

145 Total Publications

Diagnosing Type 2 Inflammation in COPD: Comparison of Blood and Sputum Eosinophil Assessment in the University of California Los Angeles COPD Phenotyping Study.
Diagnosing Type 2 Inflammation in COPD: Comparison of Blood and Sputum Eosinophil Assessment in the University of California Los Angeles COPD Phenotyping Study.
Journal: Chronic obstructive pulmonary diseases (Miami, Fla.)
Published: August 07, 2025
Similar Doctors
Distinguished in Asthma in Children
Dr. Abraham M. Ishaaya
Pulmonary Medicine | Geriatrics | Sleep Medicine
Distinguished in Asthma in Children
Dr. Abraham M. Ishaaya
Pulmonary Medicine | Geriatrics | Sleep Medicine

Abraham Ishaaya M D A Professional Corporation

5901 W Olympic Blvd, Suite 200, 
Los Angeles, CA 
 (5.0 miles away)
323-954-1788
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Abraham Ishaaya is a Pulmonary Medicine specialist and a Geriatrics provider in Los Angeles, California. Dr. Ishaaya is rated as a Distinguished provider by MediFind in the treatment of Asthma in Children. His top areas of expertise are Asthma, Asthma in Children, Pneumonia, Gastrostomy, and Colonoscopy.

Distinguished in Asthma in Children
Dr. Mark D. Weissig
Pulmonary Medicine
Distinguished in Asthma in Children
Dr. Mark D. Weissig
Pulmonary Medicine
2141 North Harbor Boulevard, Suite 25000, 
Fullerton, CA 
 (32.4 miles away)
714-626-8650
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Weissig is a Pulmonary Medicine provider in Fullerton, California. Dr. Weissig is rated as a Distinguished provider by MediFind in the treatment of Asthma in Children. His top areas of expertise are Interstitial Lung Disease, Asthma in Children, Asthma, and Acute Interstitial Pneumonia. Dr. Weissig is currently accepting new patients.

Distinguished in Asthma in Children
Dr. Steven M. Taback
Pulmonary Medicine
Distinguished in Asthma in Children
Dr. Steven M. Taback
Pulmonary Medicine
201 South Buena Vista Street, Suite 440, 
Burbank, CA 
 (9.3 miles away)
818-842-4819
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Steven Taback is a Pulmonary Medicine provider in Burbank, California. Dr. Taback is rated as a Distinguished provider by MediFind in the treatment of Asthma in Children. His top areas of expertise are Asthma in Children, Asthma, Pleural Effusion, Gastrostomy, and Endoscopy. Dr. Taback is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Belperio's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 22 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile